FDA Inspection
Kay Chemical CompanyKay Chemical Company – FDA Inspection, Dec 5, 2025
Record Details
This FDA Inspection record concerns Kay Chemical Company, with an inspection on December 5, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · cf90f4cf-cb91-4a42-a2fc-40624243b8ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1294076
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kay Chemical Company
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 8, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kay Chemical Company
- FDA Inspection 1110551 - 2019-10-08
- FDA Inspection 912805 - 2015-01-30
- FDA Inspection 720753 - 2011-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.